XML 18 R7.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Cash Flows - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Cash Flows from Operating Activities:        
Net income $ 163,700,000 $ 137,022,000 $ 279,998,000 $ 286,516,000
Adjustments to reconcile net income to net cash provided by (used in) operating activities—        
Depreciation 56,244,000 55,562,000 165,180,000 161,589,000
Amortization of intangible assets 19,687,000 15,264,000 55,374,000 40,544,000
Impairment of cost method investment 0 0 9,311,000 0
Change in fair value of contingent consideration liabilities 78,000 3,777,000 598,000 8,064,000
Equity in (earnings) losses of unconsolidated affiliates (5,260,000) (1,931,000) 2,207,000 (64,078,000)
Amortization of debt discount and issuance costs 3,070,000 466,000 4,247,000 1,282,000
Gain on sale of property and equipment (2,246,000) (992,000) (4,218,000) (3,462,000)
Provision for credit losses 1,566,000 773,000 2,910,000 4,012,000
Deferred income tax provision (benefit) (17,443,000) 4,167,000 (19,226,000) 48,298,000
Non-cash stock-based compensation 21,431,000 13,584,000 58,323,000 41,080,000
Foreign currency (gain) loss and other non-cash items (1,505,000) 1,383,000 (4,942,000) (535,000)
Payments for contingent consideration liabilities 0 0 (590,000) 0
Changes in operating assets and liabilities, net of non-cash transactions (124,463,000) (137,908,000) 290,715,000 (623,557,000)
Net cash provided by (used in) operating activities 114,859,000 91,167,000 839,887,000 (100,247,000)
Cash Flows from Investing Activities:        
Capital expenditures (50,780,000) (66,244,000) (167,037,000) (207,645,000)
Proceeds from sale of property and equipment 5,844,000 4,854,000 18,460,000 24,247,000
Proceeds from insurance settlements related to property and equipment 73,000 490,000 271,000 501,000
Cash paid for acquisitions, net of cash, cash equivalents and restricted cash acquired (187,655,000) (329,832,000) (212,092,000) (385,165,000)
Proceeds from disposition of businesses 203,000 0 11,064,000 0
Investments in unconsolidated affiliates and other entities (778,000) (1,065,000) (9,538,000) (38,995,000)
Cash received from investments in unconsolidated affiliates and other entities 2,538,000 0 2,570,000 0
Cash paid for intangible assets 0 0 0 (67,000)
Net cash used in investing activities (230,555,000) (391,797,000) (356,302,000) (607,124,000)
Cash Flows from Financing Activities:        
Borrowings under credit facility 478,762,000 2,118,501,000 2,453,941,000 4,834,014,000
Payments under credit facility (1,648,614,000) (1,789,924,000) (3,602,660,000) (4,038,762,000)
Proceeds from notes offering 990,130,000 0 990,130,000 0
Payments of other long-term debt (652,000) (1,356,000) (1,635,000) (1,839,000)
Net repayments of short-term debt, net of borrowings (1,761,000) (11,171,000) (6,180,000) (27,087,000)
Debt issuance and amendment costs (7,794,000) (2,036,000) (7,794,000) (2,036,000)
Payments for contingent consideration liabilities 0 0 (10,399,000) 0
Distributions to non-controlling interests (744,000) (489,000) (4,669,000) (2,109,000)
Payments related to tax withholding for stock-based compensation (830,000) (611,000) (24,403,000) (15,955,000)
Payment of dividends (7,001,000) (5,803,000) (21,545,000) (17,385,000)
Repurchase of common stock 0 0 (200,000,000) (20,092,000)
Net cash provided by (used in) financing activities (198,504,000) 307,111,000 (435,214,000) 708,749,000
Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash 449,000 (87,000) 986,000 (123,000)
Net increase (decrease) in cash, cash equivalents and restricted cash (313,751,000) 6,394,000 49,357,000 1,255,000
Cash, cash equivalents and restricted cash, beginning of period 532,853,000 78,117,000 169,745,000 83,256,000
Cash, cash equivalents and restricted cash, end of period $ 219,102,000 $ 84,511,000 $ 219,102,000 $ 84,511,000